Not Signed In -
Rheumatoid Arthritis |
|
|
Clinical Trial: Safety and Efficacy Study of Etanercept (Enbrel®) In Children with Systemic Onset Juvenile Rheumatoid Arthritis
This study is no longer recruiting patients.
|
Purpose
This study will determine the efficacy of etanercept in children with systemically active systemic onset juvenile rheumatoid arthritis (SOJRA).
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Arthritis, Juvenile Rheumatoid | Drug: Enbrel® | Phase III |
MedlinePlus related topics: Juvenile Rheumatoid Arthritis
Study Type: Interventional
Study Design: Treatment, Placebo Control, Safety/Efficacy Study
Official Title: Phase 3 Safety and Efficacy Study of Etanercept (Enbrel®) In Children with Systemic Onset Juvenile Rheumatoid Arthritis
Eligibility
Ages Eligible for Study: 2 Years - 18 Years, Genders Eligible for Study: Both
Criteria
- Patients must have systemic features of SOJRA
- Active joints
- Abnormal labs; albumin, platelets, Hgb, CRP
- Stable dose of Prednisone
- Stable dose or Off Methotrexate for 4 weeks
- Blinded, placebo controlled
Location Information
Idaho
Research Center, Boise, Idaho, United States
Massachusetts
Research Center, Boston, Massachusetts, United States
Canada, British Columbia
Research Center, Vancouver, British Columbia, Canada
Canada, Nova Scotia
Research Center, Halifax, Nova Scotia, Canada
Canada, Ontario
Research Center, Toronto, Ontario, Canada
Canada, Quebec
Research Center, Montreal, Quebec, Canada
More Information
AmgenTrials clinical trials website
Center Watch Clinical Trials Listing Service
Study ID Numbers: 20021631
Record last reviewed: February 2005
Last Updated: February 4, 2005
Record first received: March 5, 2004
ClinicalTrials.gov Identifier: NCT00078806
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: February 2005
Last Updated: February 4, 2005
Record first received: March 5, 2004
ClinicalTrials.gov Identifier: NCT00078806
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
